WT1 and acute myeloid leukemia: To determine whether methylation at the WT1 locus is a useful marker for disease monitoring we performed pyroseqeuncing for the WT1 and AWT1 promoters in a series of 9 AML patients before and after allogeneic SCT for whom WT1 expression had been previously determined [14].